Clinical trial
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group Study of the Efficacy and Safety of a Single Administration of F14 for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Replacement
NCT05603832 is registered in ClinicalTrials.gov with Arthritis Innovation Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group Study of the Efficacy and Safety of a Single Administration of F14 for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Replacement
- Lead sponsor
- Arthritis Innovation Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 17, 2022
- Completion date
- August 23, 2024
- Enrollment
- 151 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
post operative pain